Adjunctive Therapy With 25-hydroxyvitamin D And Articles Therefor


Methods, compositions, and kits for adjunctive therapy using 25-hydroxyvitamin D are disclosed. The 25-hydroxyvitamin D may be administered with an agent that increases the risk of hypocalcemia, such as cinacalcet or a salt thereof, and/or an anticancer agent. The adjunctive therapy is effective to treat and prevent iatrogenic hypocalcemia and/or secondary hyperparathyroidism, as well as delay cancer progression and the time to a post-treatment skeletal related event.

IPC Classifications
Download PDF
Document Preview
Document History
  • Publication: Dec 3, 2019
  • Application: Jan 9, 2019
    US US 201916243549 A
  • Priority: Jan 9, 2019
    US US 201916243549 A
  • Priority: Sep 25, 2015
    US US 201514866155 A
  • Priority: Aug 6, 2015
    EP EP 2015068219 W
  • Priority: Aug 7, 2014
    US US 201462034604 P

Download Citation

Sign in to the Lens